Sacroiliac Joint Fusion Global Market Report 2024

The sacroiliac joint fusion market size has grown rapidly in recent years. It will grow from $0.57 billion in 2023 to $0.68 billion in 2024 at a compound annual growth rate (CAGR) of 17.8%. The growth observed in the historical period can be attributed to factors such as the prevalence of chronic diseases, an increase in the incidence of joint pains, improved accessibility to and acceptance of advanced surgical techniques, a rise in demand for safer joint fusion systems, and expanded reimbursement coverage for minimally invasive sacroiliac joint fusion procedures.

The sacroiliac joint fusion market size is expected to see rapid growth in the next few years. It will grow to $1.32 billion in 2028 at a compound annual growth rate (CAGR) of 18.1%. The anticipated growth in the forecast period is expected to be driven by factors such as the increasing prevalence of lower back pain, rising incidence of sacroiliitis or sacroiliac joint dysfunction, growing demand for procedures offering reduced levels of pain and fatigue, rising preference for minimally invasive surgeries, and the expanding geriatric population. Significant trends projected for this period encompass investments in innovative technologies and procedures, the adoption of new materials and technologies, enhancements in diagnostic capabilities for sacroiliac joint disorders, utilization of 3D-printed titanium implants and additive manufacturing techniques, as well as advancements in healthcare infrastructure.

The rising prevalence of lower back pain is poised to propel the expansion of the sacroiliac joint fusion market in the foreseeable future. Lower back pain, characterized by discomfort or pain in the lumbar region of the spine, ranging from a persistent dull ache to sudden, sharp pain, is a common ailment influenced by factors such as work stress, sedentary lifestyles, obesity, and dietary habits. Sacroiliac joint fusion, a surgical procedure, addresses lower back pain by stabilizing the joint and reducing abnormal movement, thereby enhancing overall function and quality of life. For instance, according to an article published by the National Center For Biotechnology Information, a US-based government agency, in May 2023, low back pain (LBP) affected 619 million individuals worldwide in 2020, with projections indicating an increase to 843 million by 2050. Hence, the escalating prevalence of lower back pain is a driving force behind the growth of the sacroiliac joint fusion market.

Prominent players in the sacroiliac joint fusion market are focusing on the development of innovative implants, such as the granite implant systems, to optimize patient outcomes, streamline surgical procedures, and enhance overall efficacy. The granite implant system for SI joint fusion is specifically designed to address conditions affecting the sacroiliac joint, offering improved joint stabilization and fusion for patients suffering from sacroiliac joint dysfunction or sacroiliitis. For example, in May 2024, SI-BONE Inc., a UK-based healthcare company specializing in the surgical treatment of musculoskeletal disorders, introduced the iFuse Bedrock Granite Implant System. This advanced implant, designed for sacroiliac fusion and spinopelvic fixation, is crucial for multi-segment spinal fusion procedures. Recognized with a Breakthrough Device Designation from the FDA and a new technology add-on payment from CMS, the iFuse Bedrock Granite Implant System represents a significant advancement in addressing SI joint dysfunction and offers a dependable option for individuals experiencing chronic lower back pain related to SI joint issues.

In November 2023, Nevro Corp, a US-based medical device company, acquired Vyrsa Technologies for $75 million. This strategic acquisition underscores Nevro's commitment to expanding its portfolio by integrating Vyrsa's expertise in providing minimally invasive treatment options for patients with chronic sacroiliac (SI) joint pain. Vyrsa Technologies, a US-based company focused on minimally invasive treatments for individuals with chronic sacroiliac joint (SI joint) pain, aligns with Nevro's objective of advancing treatment options in this specialized area.

Major companies operating in the sacroiliac joint fusion market are Medtronic Plc, Zimmer Biomet Holdings Inc., Integra LifeSciences, Saint Francis Health System, NuVasive Inc., Globus Medical, Orthofix Inc., Medacta International SA, Alphatec Holdings Inc., RTI Surgical Holdings Inc., SeaSpine, SI-BONE Inc., Surgalign Holdings Inc., Xtant Medical, CoreLink, Life Spine Inc., Genesys Spine, Camber Spine Technologies LLC, Captiva Spine Inc., VGI Medical LLC, PainTEQ, CornerLoc, SIGNUS Medizintechnik GmbH, Tenon Medical Inc.

North America was the largest region in the sacroiliac joint fusion market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sacroiliac joint fusion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sacroiliac joint fusion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Sacroiliac joint fusion is a surgical intervention intended to alleviate pain originating from the sacroiliac joint by permanently connecting the sacrum (the triangular bone at the spine's base) to the ilium (part of the pelvis) through surgical implants or bone grafts. This fusion procedure restricts movement in the joint, thereby reducing or eliminating pain caused by joint instability, inflammation, or degenerative conditions.

The primary product categories related to sacroiliac joint fusion include implants, accessories, injections, diagnosis, treatment, and RF ablation. Implants utilized in SI joint fusion are medical devices engineered to stabilize and facilitate the fusion process of the SI joint. Various indications for this procedure include degenerative sacroiliitis, sacral disruption, and trauma, with approaches including dorsal and anterior methods. These products cater to diverse end-users such as hospitals, ambulatory surgical centers, and others.

The sacroiliac joint fusion market research report is one of a series of new reports that provides sacroiliac joint fusion market statistics, including sacroiliac joint fusion industry global market size, regional shares, competitors with a sacroiliac joint fusion market share, detailed sacroiliac joint fusion market segments, market trends, and opportunities, and any further data you may need to thrive in the sacroiliac joint fusion industry. This sacroiliac joint fusion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sacroiliac joint fusion market consists of revenues earned by entities through surgical procedures, diagnostic services, rehabilitation and post-operative care, consultation services, and hospital and surgical center services. The market value includes the value of related goods sold by the service provider or included within the service offering. The sacroiliac joint fusion market also includes sales of SI joint fusion implants, surgical instruments, bone grafts and substitutes, navigation and imaging systems, fixation devices, and minimally invasive surgical kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.